publication date: Jun. 30, 2017

Buchholz, Dmitrovsky and Fontaine lose authority at MD Anderson as executive vice president positions are eliminated

By Paul Goldberg

MD Anderson has simplified its power structure, eliminating the three executive vice president positions and flattening out the box diagram, with six vice presidents and senior vice presidents reporting directly to the president.

“These changes create a more diverse leadership team, built of leaders who know the institution and its needs,” the institution said in a press release. “No new hires or additional costs are needed to support the new structure.”

Tom Buchholz, former physician-in-chief, will remain professor of radiation oncology and will also remain engaged in the institution’s philanthropic and corporate sponsorship activities, officials said. His former job is reclassified as chief medical officer, and Karen Lu, the chair of the Department of Gynecologic Oncology and Reproductive Medicine will serve in that capacity on interim basis.

Ethan Dmitrovsky, former provost, will work on MD Anderson’s Cancer Center Support Grant and will “return to his scholarship at MD Anderson,” according to a statement. The job of provost is being reclassified as chief academic officer. Steven Sherman, associate vice provost of clinical research and chair of the Department of Endocrine Neoplasia and Hormonal Disorders will serve in that position on interim basis.

Former EVP Dan Fontaine, an attorney and former senior vice president for … Continue reading Buchholz, Dmitrovsky and Fontaine lose authority at MD Anderson as executive vice president positions are eliminated

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2017 The Cancer Letter Inc.